aluates Reports

$ 0.0

Automative

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-36X1173

Global Colorectal Cancer Molecular Diagnostics Market Insights Forecast to 2028

BUY CHAPTERS

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-36X1173

Report

March 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent

Qiagen

Roche Diagnostics

Thermo Fisher

Illumina Inc

Biomerieux

Bio Rad

Daangene

Amoydx

Qiagen NV

Abbott

Colorectal Cancer Molecular Diagnostics Market Size

The global market for Colorectal Cancer Molecular Diagnostics was valued at US$ 772 million in the year 2024 and is projected to reach a revised size of US$ 1926 million by 2031, growing at a CAGR of 14.2% during the forecast period.

Colorectal Cancer Molecular Diagnostics Market

Colorectal Cancer Molecular Diagnostics refers to the use of molecular techniques to detect specific genetic mutations, biomarkers, and molecular alterations associated with colorectal cancer. These diagnostics help in identifying cancer subtypes, predicting the patient's response to treatment, and assessing the risk of cancer recurrence. Methods used in molecular diagnostics include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH), among others. By providing personalized information about the tumor’s genetic profile, molecular diagnostics enable targeted therapies and improve the precision of treatment plans for colorectal cancer patients.

Colorectal Cancer Molecular Diagnostics Market Drivers:

Rising Prevalence of Colorectal Cancer: As colorectal cancer remains one of the most common cancers globally, the growing number of cases is a key driver for the molecular diagnostics market. Early detection and personalized treatment approaches are increasingly in demand.

Advancements in Molecular Diagnostics Technology: Innovations like next-generation sequencing (NGS), liquid biopsy, and biomarker discovery have improved the accuracy and efficiency of diagnostics, making them more accessible and appealing to healthcare providers and patients.

Personalized Medicine and Targeted Therapies: The shift toward personalized treatment in oncology, where therapies are tailored based on the patient’s genetic profile, is driving the adoption of molecular diagnostics to identify specific mutations and biomarkers in colorectal cancer.

Increasing Awareness and Screening Programs: Governments and health organizations are promoting regular colorectal cancer screenings, driving the demand for advanced diagnostic tests.

Colorectal Cancer Molecular Diagnostics Market Challenges:

High Costs and Reimbursement Issues: Advanced molecular diagnostics can be expensive, and the lack of consistent reimbursement policies across different regions limits their widespread adoption, particularly in low- and middle-income countries.

Complexity of Genetic Data Interpretation: As molecular diagnostics provide a vast amount of genetic data, interpreting these results requires specialized expertise. This can create a barrier in regions where access to highly skilled professionals is limited.

Regulatory Hurdles: Stringent regulations surrounding the approval and clinical use of molecular diagnostics can slow down market growth, especially when it comes to introducing new and innovative tests.

Limited Awareness in Developing Regions: While awareness of colorectal cancer and molecular diagnostics is growing in developed countries, many developing regions still face challenges related to lack of awareness and infrastructure for advanced diagnostic techniques.

Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. North America is the largest market with a share about 43%, followed by Asia-Pacific and Europe.

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics.

The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colorectal Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colorectal Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Colorectal Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Colorectal Cancer Molecular Diagnostics Market
Accounted market size in year	US$ 772 million
Forecasted market size in 2031	US$ 1926 million
CAGR	14.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Polymerase Chain Reaction PCR Molecular Hybridization Biochip Others
Segment by Application	Hospital Third-Party Testing Agency Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Colorectal Cancer Molecular Diagnostics Market growing?

Ans: The Colorectal Cancer Molecular Diagnostics Market witnessing a CAGR of 14.2% during the forecast period 2025-2031.

What is the Colorectal Cancer Molecular Diagnostics Market size in 2031?

Ans: The Colorectal Cancer Molecular Diagnostics Market size in 2031 will be US$ 1926 million.

What is the market share of major companies in Colorectal Cancer Molecular Diagnostics Market?

Ans: The top 3 companies hold a share about 45%.

What is the Colorectal Cancer Molecular Diagnostics Market share by region?

Ans: North America is the largest market with a share about 43%, followed by Asia-Pacific and Europe.

Who are the main players in the Colorectal Cancer Molecular Diagnostics Market report?

Ans: The main players in the Colorectal Cancer Molecular Diagnostics Market are Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx

What are the Application segmentation covered in the Colorectal Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Colorectal Cancer Molecular Diagnostics Market report are Hospital, Third-Party Testing Agency, Others

What are the Type segmentation covered in the Colorectal Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Colorectal Cancer Molecular Diagnostics Market report are Polymerase Chain Reaction PCR, Molecular Hybridization, Biochip, Others

Recommended Reports

Cancer Molecular Diagnostics

Cancer Diagnostic Solutions

Molecular Technology Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction PCR

1.2.3 Molecular Hybridization

1.2.4 Biochip

1.2.5 Others

1.3 Market by Application

1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Third-Party Testing Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2020-2031)

2.2 Global Colorectal Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Colorectal Cancer Molecular Diagnostics Market Dynamics

2.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends

2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers

2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges

2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Colorectal Cancer Molecular Diagnostics Revenue

3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2024

3.5 Global Key Players of Colorectal Cancer Molecular Diagnostics Head office and Area Served

3.6 Global Key Players of Colorectal Cancer Molecular Diagnostics, Product and Application

3.7 Global Key Players of Colorectal Cancer Molecular Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)

5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)

6.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)

6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)

7.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)

7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)

9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Introduction

11.1.4 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.1.5 Roche Diagnostics Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction

11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 Thermo Fisher

11.3.1 Thermo Fisher Company Details

11.3.2 Thermo Fisher Business Overview

11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Introduction

11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.3.5 Thermo Fisher Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction

11.4.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.4.5 Qiagen Recent Development

11.5 Illumina

11.5.1 Illumina Company Details

11.5.2 Illumina Business Overview

11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Introduction

11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.5.5 Illumina Recent Development

11.6 Biomerieux

11.6.1 Biomerieux Company Details

11.6.2 Biomerieux Business Overview

11.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Introduction

11.6.4 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.6.5 Biomerieux Recent Development

11.7 Bio-Rad

11.7.1 Bio-Rad Company Details

11.7.2 Bio-Rad Business Overview

11.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Introduction

11.7.4 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.7.5 Bio-Rad Recent Development

11.8 Agilent

11.8.1 Agilent Company Details

11.8.2 Agilent Business Overview

11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction

11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.8.5 Agilent Recent Development

11.9 Daangene

11.9.1 Daangene Company Details

11.9.2 Daangene Business Overview

11.9.3 Daangene Colorectal Cancer Molecular Diagnostics Introduction

11.9.4 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.9.5 Daangene Recent Development

11.10 Amoydx

11.10.1 Amoydx Company Details

11.10.2 Amoydx Business Overview

11.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Introduction

11.10.4 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

11.10.5 Amoydx Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent

Qiagen

Roche Diagnostics

Thermo Fisher

Illumina Inc

Biomerieux

Bio Rad

Daangene

Amoydx

Qiagen NV

Abbott

List of Tables

Table 1. Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction PCR

Table 3. Key Players of Molecular Hybridization

Table 4. Key Players of Biochip

Table 5. Key Players of Others

Table 6. Global Colorectal Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2020-2025)

Table 10. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Colorectal Cancer Molecular Diagnostics Market Share by Region (2026-2031)

Table 12. Colorectal Cancer Molecular Diagnostics Market Trends

Table 13. Colorectal Cancer Molecular Diagnostics Market Drivers

Table 14. Colorectal Cancer Molecular Diagnostics Market Challenges

Table 15. Colorectal Cancer Molecular Diagnostics Market Restraints

Table 16. Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2024)

Table 19. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Colorectal Cancer Molecular Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Colorectal Cancer Molecular Diagnostics, Product and Application

Table 23. Global Key Players of Colorectal Cancer Molecular Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Diagnostics Company Details

Table 49. Roche Diagnostics Business Overview

Table 50. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product

Table 51. Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Roche Diagnostics Recent Development

Table 53. Abbott Company Details

Table 54. Abbott Business Overview

Table 55. Abbott Colorectal Cancer Molecular Diagnostics Product

Table 56. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Abbott Recent Development

Table 58. Thermo Fisher Company Details

Table 59. Thermo Fisher Business Overview

Table 60. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product

Table 61. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Recent Development

Table 63. Qiagen Company Details

Table 64. Qiagen Business Overview

Table 65. Qiagen Colorectal Cancer Molecular Diagnostics Product

Table 66. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 67. Qiagen Recent Development

Table 68. Illumina Company Details

Table 69. Illumina Business Overview

Table 70. Illumina Colorectal Cancer Molecular Diagnostics Product

Table 71. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Illumina Recent Development

Table 73. Biomerieux Company Details

Table 74. Biomerieux Business Overview

Table 75. Biomerieux Colorectal Cancer Molecular Diagnostics Product

Table 76. Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Biomerieux Recent Development

Table 78. Bio-Rad Company Details

Table 79. Bio-Rad Business Overview

Table 80. Bio-Rad Colorectal Cancer Molecular Diagnostics Product

Table 81. Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Bio-Rad Recent Development

Table 83. Agilent Company Details

Table 84. Agilent Business Overview

Table 85. Agilent Colorectal Cancer Molecular Diagnostics Product

Table 86. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Agilent Recent Development

Table 88. Daangene Company Details

Table 89. Daangene Business Overview

Table 90. Daangene Colorectal Cancer Molecular Diagnostics Product

Table 91. Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 92. Daangene Recent Development

Table 93. Amoydx Company Details

Table 94. Amoydx Business Overview

Table 95. Amoydx Colorectal Cancer Molecular Diagnostics Product

Table 96. Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Amoydx Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Colorectal Cancer Molecular Diagnostics Picture

Figure 2. Global Colorectal Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Colorectal Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction PCR Features

Figure 5. Molecular Hybridization Features

Figure 6. Biochip Features

Figure 7. Others Features

Figure 8. Global Colorectal Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Third-Party Testing Agency Case Studies

Figure 12. Others Case Studies

Figure 13. Colorectal Cancer Molecular Diagnostics Report Years Considered

Figure 14. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Colorectal Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Colorectal Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Colorectal Cancer Molecular Diagnostics Market Share by Players in 2024

Figure 18. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2024

Figure 20. North America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Region (2020-2031)

Figure 34. China Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Roche Diagnostics Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 50. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 51. Thermo Fisher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 52. Qiagen Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 53. Illumina Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 54. Biomerieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 55. Bio-Rad Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 56. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 57. Daangene Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 58. Amoydx Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Research Report 2024

Colorectal Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnosis of Rectal Cancer Market Research Report 2024

Global Viral Molecular Diagnostics Market Research Report 2024

Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030

Global Molecular Microbiology Market Insights Forecast to 2030

Global Colorectal Cancer Screening Test Market Research Report 2024

Global Molecular Oncology Market Research Report 2024

Global Point of care Molecular Diagnostic Solution Market Research Report 2025

Veterinary Molecular Diagnostics Market

Global Cancer Molecular Biomarkers Market Research Report 2024

In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colorectal Cancer Molecular Diagnostics Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnostics in Infectious Disease Testing Market Research Report 2024

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Molecular Diagnostics Infectious Disease Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions